"The addition of Viz RECRUIT to the APEX-AV study team is the perfect marriage of artificial intelligence blended with new technology to streamline enrollment in this important trial in the PE space."
Viz.ai software is now reimbursed by Medicare as a “New Technology Add-on Payment” when used in the ER to help diagnose suspected LVO cases.
A recent, large, real-world multi-centre study using Viz.ai found a median time-to-notification of five minutes and 45 seconds across all of the sites involved when using Viz LVO.
CHRISTUS Southeast Texas St. Elizabeth, St. Mary Mid-County, and Jasper Memorial Hospital are improving treatment for stroke patients with the success of the CHRISTUS Southeast Texas Stroke Program and their use of technology. The program offers the most current approach to treating stroke patients and meets the highest standards of safety goals and standards.
Rosemarie, who accompanied her husband in the ambulance to Albany Medical Center, was amazed by how quickly after his arrival that Dr. Paul was able to complete the procedure to relieve the blockage.
It’s no surprise that among the 206 new 2022 "unicorns," a boatload are in artificial intelligence and machine learning.
Second up in our Champions of Change spotlight series is a conversation with the remarkable Angela Lim, vice president and deputy general counsel at Viz.ai. In the past 25+ years, Angela has bridged her intersectional Asian LGBTQ identity and her board service work to create an impact on health equity.
Ohio-based Mercy Health – Springfield Regional Medical Center has partnered with Viz.ai to implement artificial intelligence technology to support faster detection and notification of strokes.
These healthcare startups clinched valuations of $1 billion or more this year, even as investors ease off venture funding in an unstable market.
Mayfield Brain & Spine neurosurgeon Dr. Jonathan Hodes explains how they're using Viz.ai to identify patients who may be having a stroke and get them to the operating room faster.
Viz.ai's AI-Powered Pulmonary Embolism and Aortic Disease Modules named as a finalist in Fast Company's 2022 World Changing Ideas Awards.